NC Medical Research Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.54M

  • Investors
  • 5

NC Medical Research General Information

Description

Developer of a regenerative drug designed to treat cerebral infarctions. The company's product utilizes human bone marrow-derived mesenchymal stem cells as raw material, using a unique manufacturing process, to reduce cerebral infarction size and improve neural function, enabling healthcare providers to have a more effective method over currently followed thrombolytic therapy to treat cerebral infarctions in patients.

Contact Information

Website
www.ncmr.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Shiroyama Trust Tower 17th Floor
  • 4-3-1, Toranomon, Minato-ku
  • Tokyo, 105-6017
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Shiroyama Trust Tower 17th Floor
  • 4-3-1, Toranomon, Minato-ku
  • Tokyo, 105-6017
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NC Medical Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 05-Aug-2021 $4.54M Completed Clinical Trials - General
10. Later Stage VC 01-Apr-2020 Completed Clinical Trials - General
9. Later Stage VC 01-Apr-2019 Completed Pre-Clinical Trials
8. Later Stage VC 19-Jul-2018 Completed Pre-Clinical Trials
7. Later Stage VC 01-Dec-2017 Completed Pre-Clinical Trials
6. Later Stage VC 01-Feb-2012 Completed Startup
5. Later Stage VC 01-Apr-2011 Completed Startup
4. Later Stage VC 01-May-2009 Completed Startup
3. Early Stage VC 01-Sep-2008 Completed Startup
2. Early Stage VC 01-Nov-2007 Completed Startup
To view NC Medical Research’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NC Medical Research Patents

  • 43

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

NC Medical Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2017145259-A Cell therapy for treatment of neurodegeneration Active 01-Jun-2017
US-20180353577-A1 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
US-20140219969-A1 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
US-10071144-B2 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
US-10874723-B2 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013 C12N5/0669
To view NC Medical Research’s complete patent history, request access »

NC Medical Research Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alfresa Holdings Corporation Minority
CMIC Holdings Holding Company Minority
Urban Corporation Corporation Minority
Mitsubishi Gas Chemical Corporation Minority
FujiFilm (Diagnostic Equipment) VC-Backed Company Minority
To view NC Medical Research’s complete investors history, request access »

Ready to get started?

Request a free trial

NC Medical Research FAQs

  • When was NC Medical Research founded?

    NC Medical Research was founded in 2004.

  • Where is NC Medical Research headquartered?

    NC Medical Research is headquartered in Tokyo, Japan.

  • What industry is NC Medical Research in?

    NC Medical Research’s primary industry is Drug Discovery.

  • Is NC Medical Research a private or public company?

    NC Medical Research is a Private company.

  • What is the current valuation of NC Medical Research?

    The current valuation of NC Medical Research is .

  • What is NC Medical Research’s current revenue?

    The current revenue for NC Medical Research is .

  • How much funding has NC Medical Research raised over time?

    NC Medical Research has raised $4.54M.

  • Who are NC Medical Research’s investors?

    Alfresa Holdings, CMIC Holdings, Urban Corporation, Mitsubishi Gas Chemical, and FujiFilm (Diagnostic Equipment) have invested in NC Medical Research.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »